Viewing Study NCT05128734

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2026-03-03 @ 2:19 PM
Study NCT ID: NCT05128734
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-15
First Post: 2021-10-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
Sponsor: AHS Cancer Control Alberta
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer Triple Negative View
Keywords:

Keywords

Keyword Brief Keyword Text View
None METHYLATED 06-methylguanine-DNA methyltransferase (MGMT) View
None Triple-Negative Breast Cancer View
None TNBC View
None Temozolomide View
None Olaparib View